GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Net Margin %

Baskhanbiopharma (XKRX:354390) Net Margin % : 9.13% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Baskhanbiopharma Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Baskhanbiopharma's Net Income for the six months ended in Dec. 2023 was ₩2,778 Mil. Baskhanbiopharma's Revenue for the six months ended in Dec. 2023 was ₩30,423 Mil. Therefore, Baskhanbiopharma's net margin for the quarter that ended in Dec. 2023 was 9.13%.

The historical rank and industry rank for Baskhanbiopharma's Net Margin % or its related term are showing as below:

XKRX:354390' s Net Margin % Range Over the Past 10 Years
Min: -1.56   Med: 1.12   Max: 9.13
Current: 9.13


XKRX:354390's Net Margin % is ranked better than
67.19% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 3.065 vs XKRX:354390: 9.13

Baskhanbiopharma Net Margin % Historical Data

The historical data trend for Baskhanbiopharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baskhanbiopharma Net Margin % Chart

Baskhanbiopharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Margin %
-1.56 1.60 0.63 9.13

Baskhanbiopharma Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Net Margin % -1.56 1.60 0.63 9.13

Competitive Comparison of Baskhanbiopharma's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Baskhanbiopharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baskhanbiopharma's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Baskhanbiopharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Baskhanbiopharma's Net Margin % falls into.



Baskhanbiopharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Baskhanbiopharma's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=2778.435/30423.119
=9.13 %

Baskhanbiopharma's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=2778.435/30423.119
=9.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baskhanbiopharma  (XKRX:354390) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Baskhanbiopharma Net Margin % Related Terms

Thank you for viewing the detailed overview of Baskhanbiopharma's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Baskhanbiopharma (XKRX:354390) Business Description

Traded in Other Exchanges
N/A
Address
354 Wondang-ro, Wongok-myeon, Anseong-si, Gyeonggi-do, KOR
Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.

Baskhanbiopharma (XKRX:354390) Headlines

No Headlines